Back
Plus Therapeutics Stock Price Chart

Your Chance To Invest In The Green Energy Revolution!
Don't miss this one - click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!
Buy
55
PSTV
Plus Therapeutics
Last Price:
0.43
Seasonality Move:
-0.55%
7 Day Trial
ALL ACCESS PASS
$
7

New Year, New Trades, Try A.I. Today
Learn to forecast trends with up to 87.4% proven accuracy -> Register Here- The current trend is moderately bullish and PSTV is experiencing slight buying pressure.
Plus Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.45 | Sell |
20-day SMA: | 0.39 | Buy |
50-day SMA: | 0.39 | Buy |
200-day SMA: | 0.54 | Sell |
8-day EMA: | 0.43 | Buy |
20-day EMA: | 0.4 | Buy |
50-day EMA: | 0.41 | Buy |
200-day EMA: | 0.62 | Sell |
Plus Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 60.39 | Buy |
Chaikin Money Flow: | 57817 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.31 - 0.43) | Buy |
Bollinger Bands (100): | (0.35 - 0.57) | Sell |
Plus Therapeutics Technical Analysis
Jan-11 | Jan-12 | Jan-13 | Jan-17 | Jan-18 | Jan-19 | Jan-20 | Jan-23 | Jan-24 | Jan-25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
11 | 12 | 13 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Plus Therapeutics Stock
Is Plus Therapeutics Stock a Buy?
- Plus Therapeutics share price is 0.44 while PSTV 8-day simple moving average is 0.45, which is a Sell signal.
- The stock price of PSTV is 0.44 while Plus Therapeutics 20-day SMA is 0.39, which makes it a Buy.
- Plus Therapeutics 50-day simple moving average is 0.39 while PSTV share price is 0.44, making it a Buy technically.
- PSTV stock price is 0.44 and Plus Therapeutics 200-day simple moving average is 0.54, creating a Sell signal.
PSTV Technical Analysis vs Fundamental Analysis
Buy
55
Plus Therapeutics (PSTV)
is a Buy
Is Plus Therapeutics a Buy or a Sell?
-
Plus Therapeutics stock is rated a Buy
The current Plus Therapeutics [PSTV] share price is $0.44. The Score for PSTV is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Plus Therapeutics Stock Info
Market Cap:
14.78M
Price in USD:
0.44
Share Volume:
135.55K
Plus Therapeutics 52-Week Range
52-Week High:
1.20
52-Week Low:
0.29
Buy
55
Plus Therapeutics (PSTV)
is a Buy
Plus Therapeutics Share Price Forecast
-
What is the Plus Therapeutics stock price today?
The Plus Therapeutics stock price is 0.44 USD today. -
Will PSTV stock go up or go down?
Plus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Plus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Plus Therapeutics is not overvalued.
Is Plus Therapeutics Stock a Buy?
- Plus Therapeutics share price is 0.44 while PSTV 8-day exponential moving average is 0.43, which is a Buy signal.
- The stock price of PSTV is 0.44 while Plus Therapeutics 20-day EMA is 0.40, which makes it a Buy.
- Plus Therapeutics 50-day exponential moving average is 0.41 while PSTV share price is 0.44, making it a Buy technically.
- PSTV stock price is 0.44 and Plus Therapeutics 200-day simple moving average is 0.62, creating a Sell signal.
Fundamental Analysis of Plus Therapeutics
Is Plus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and a decrease next year of $0.27 per share.
Technical Analysis of Plus Therapeutics
Should I short Plus Therapeutics stock?
- PSTV Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting Plus Therapeutics is a Buy
- Plus Therapeutics Relative Strength Index (RSI) is 60.39, which suggest Plus Therapeutics is overbought
- The Bollinger Bands (25) for Plus Therapeutics is (0.31 - 0.43), which suggest Plus Therapeutics is a Sell
- The Bollinger Bands (100) for Plus Therapeutics is (0.35 - 0.57), which suggest Plus Therapeutics is a Sell
* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.